With more brains and money, Chinese firms moved beyond copying Western drugs. Instead of waiting for patents to expire and making identical generics, they adopted a "fast-follower" strategy—taking known drugs and modifying them to improve safety, efficacy or delivery.
It's not just AI. China's medicines are surprising the world, too
https://www.economist.com/business/2025/02/16/its-not-just-ai-chinas-medicines-are-surprising-the-world-too
from The Economist
Best Regards
Seetha Ram
It's not just AI. China's medicines are surprising the world, too
https://www.economist.com/business/2025/02/16/its-not-just-ai-chinas-medicines-are-surprising-the-world-too
from The Economist
Best Regards
Seetha Ram
Comments
Post a Comment